The HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivo

Patients with actively replicating human immunodeficiency virus (HIV) exhibit adverse reactions even to low irradiation doses. High levels of the virus-encoded viral protein R (Vpr) are believed to be one of the major underlying causes for increased radiosensitivity. As Vpr efficiently crosses the b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kübler, Jens (VerfasserIn) , Kirschner, Stefanie (VerfasserIn) , Hartmann, Linda (VerfasserIn) , Welzel, Grit (VerfasserIn) , Engelhardt, Maren (VerfasserIn) , Herskind, Carsten (VerfasserIn) , Veldwijk, Marlon Romano (VerfasserIn) , Schultz, Christian (VerfasserIn) , Felix, Manuela (VerfasserIn) , Glatting, Gerhard (VerfasserIn) , Maier, Patrick (VerfasserIn) , Wenz, Frederik (VerfasserIn) , Giordano, Frank Anton (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 2, 2016
In: OncoTarget
Year: 2016, Jahrgang: 7, Heft: 29, Pages: 45500-45512
ISSN:1949-2553
DOI:10.18632/oncotarget.9787
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.18632/oncotarget.9787
Verlag, kostenfrei, Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=9787&path[]=31520
Volltext
Verfasserangaben:Jens Kübler, Stefanie Kirschner, Linda Hartmann, Grit Welzel, Maren Engelhardt, Carsten Herskind, Marlon R. Veldwijk, Christian Schultz, Manuela Felix, Gerhard Glatting, Patrick Maier, Frederik Wenz, Marc A. Brockmann, Frank A. Giordano

MARC

LEADER 00000caa a2200000 c 4500
001 1668783266
003 DE-627
005 20230427221603.0
007 cr uuu---uuuuu
008 190708s2016 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.9787  |2 doi 
035 |a (DE-627)1668783266 
035 |a (DE-599)KXP1668783266 
035 |a (OCoLC)1341233247 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kübler, Jens  |d 1990-  |e VerfasserIn  |0 (DE-588)1139471937  |0 (DE-627)897209060  |0 (DE-576)493311157  |4 aut 
245 1 4 |a The HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivo  |c Jens Kübler, Stefanie Kirschner, Linda Hartmann, Grit Welzel, Maren Engelhardt, Carsten Herskind, Marlon R. Veldwijk, Christian Schultz, Manuela Felix, Gerhard Glatting, Patrick Maier, Frederik Wenz, Marc A. Brockmann, Frank A. Giordano 
264 1 |c June 2, 2016 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.07.2019 
500 |a Im Titel ist "52-96" tiefgestellt 
520 |a Patients with actively replicating human immunodeficiency virus (HIV) exhibit adverse reactions even to low irradiation doses. High levels of the virus-encoded viral protein R (Vpr) are believed to be one of the major underlying causes for increased radiosensitivity. As Vpr efficiently crosses the blood-brain barrier and accumulates in astrocytes, we examined its efficacy as a drug for treatment of glioblastoma multiforme (GBM). In vitro, four glioblastoma-derived cell lines with and without methylguanine-DNA methyltransferase (MGMT) overexpression (U251, U87, U251-MGMT, U87-MGMT) were exposed to Vpr, temozolomide (TMZ), conventional photon irradiation (2 to 6 Gy) or to combinations thereof. Vpr showed high rates of acute toxicities with median effective doses of 4.0±1.1 μM and 15.7±7.5 μM for U251 and U87 cells, respectively. Caspase assays revealed Vpr-induced apoptosis in U251, but not in U87 cells. Vpr also efficiently inhibited clonogenic survival in both U251 and U87 cells and acted additively with irradiation. In contrast to TMZ, Vpr acted independently of MGMT expression. Dose escalation in mice (n=12) was feasible and resulted in no evident renal or liver toxicity. Both, irradiation with 3x5 Gy (n=8) and treatment with Vpr (n=5) delayed intracerebral tumor growth and prolonged overall survival compared to untreated animals (n=5; p3x5 Gy<0.001 and pVpr=0.04; log-rank test). Our data show that the HIV-encoded peptide Vpr exhibits all properties of an effective chemotherapeutic drug and may be a useful agent in the treatment of GBM. 
700 1 |a Kirschner, Stefanie  |d 1980-  |e VerfasserIn  |0 (DE-588)1075006708  |0 (DE-627)832847429  |0 (DE-576)443195234  |4 aut 
700 1 |a Hartmann, Linda  |e VerfasserIn  |0 (DE-588)1033514756  |0 (DE-627)741332558  |0 (DE-576)381120325  |4 aut 
700 1 |a Welzel, Grit  |d 1969-  |e VerfasserIn  |0 (DE-588)1034853139  |0 (DE-627)74633754X  |0 (DE-576)382474031  |4 aut 
700 1 |a Engelhardt, Maren  |d 1974-  |e VerfasserIn  |0 (DE-588)1038249716  |0 (DE-627)756831512  |0 (DE-576)392232359  |4 aut 
700 1 |a Herskind, Carsten  |d 1952-  |e VerfasserIn  |0 (DE-588)1028380488  |0 (DE-627)730637409  |0 (DE-576)375919325  |4 aut 
700 1 |a Veldwijk, Marlon Romano  |d 1973-  |e VerfasserIn  |0 (DE-588)124783562  |0 (DE-627)366051938  |0 (DE-576)294500278  |4 aut 
700 1 |a Schultz, Christian  |d 1965-  |e VerfasserIn  |0 (DE-588)1038250226  |0 (DE-627)756832500  |0 (DE-576)392232898  |4 aut 
700 1 |a Felix, Manuela  |d 1984-  |e VerfasserIn  |0 (DE-588)107500585X  |0 (DE-627)832845477  |0 (DE-576)443193258  |4 aut 
700 1 |a Glatting, Gerhard  |d 1961-  |e VerfasserIn  |0 (DE-588)1055963103  |0 (DE-627)792987675  |0 (DE-576)411974521  |4 aut 
700 1 |a Maier, Patrick  |d 1969-  |e VerfasserIn  |0 (DE-588)1022131273  |0 (DE-627)71692613X  |0 (DE-576)360534732  |4 aut 
700 1 |a Wenz, Frederik  |d 1966-  |e VerfasserIn  |0 (DE-588)113310390  |0 (DE-627)663837766  |0 (DE-576)346656281  |4 aut 
700 1 |a Giordano, Frank Anton  |d 1980-  |e VerfasserIn  |0 (DE-588)136378455  |0 (DE-627)694333093  |0 (DE-576)300990529  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 7(2016), 29, Seite 45500-45512  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a The HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivo 
773 1 8 |g volume:7  |g year:2016  |g number:29  |g pages:45500-45512  |g extent:13  |a The HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivo 
856 4 0 |u https://doi.org/10.18632/oncotarget.9787  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=9787&path[]=31520  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20190708 
993 |a Article 
994 |a 2016 
998 |g 136378455  |a Giordano, Frank Anton  |m 136378455:Giordano, Frank Anton  |d 60000  |d 63000  |e 60000PG136378455  |e 63000PG136378455  |k 0/60000/  |k 1/60000/63000/  |p 14  |y j 
998 |g 113310390  |a Wenz, Frederik  |m 113310390:Wenz, Frederik  |d 60000  |d 63000  |e 60000PW113310390  |e 63000PW113310390  |k 0/60000/  |k 1/60000/63000/  |p 12 
998 |g 1022131273  |a Maier, Patrick  |m 1022131273:Maier, Patrick  |d 60000  |d 63000  |e 60000PM1022131273  |e 63000PM1022131273  |k 0/60000/  |k 1/60000/63000/  |p 11 
998 |g 1055963103  |a Glatting, Gerhard  |m 1055963103:Glatting, Gerhard  |d 60000  |d 63000  |e 60000PG1055963103  |e 63000PG1055963103  |k 0/60000/  |k 1/60000/63000/  |p 10 
998 |g 107500585X  |a Felix, Manuela  |m 107500585X:Felix, Manuela  |d 60000  |d 63000  |e 60000PF107500585X  |e 63000PF107500585X  |k 0/60000/  |k 1/60000/63000/  |p 9 
998 |g 1038250226  |a Schultz, Christian  |m 1038250226:Schultz, Christian  |d 60000  |d 999810  |e 60000PS1038250226  |e 999810PS1038250226  |k 0/60000/  |k 1/60000/999810/  |p 8 
998 |g 124783562  |a Veldwijk, Marlon Romano  |m 124783562:Veldwijk, Marlon Romano  |d 60000  |d 63000  |e 60000PV124783562  |e 63000PV124783562  |k 0/60000/  |k 1/60000/63000/  |p 7 
998 |g 1028380488  |a Herskind, Carsten  |m 1028380488:Herskind, Carsten  |d 60000  |d 63000  |e 60000PH1028380488  |e 63000PH1028380488  |k 0/60000/  |k 1/60000/63000/  |p 6 
998 |g 1038249716  |a Engelhardt, Maren  |m 1038249716:Engelhardt, Maren  |d 60000  |d 999810  |e 60000PE1038249716  |e 999810PE1038249716  |k 0/60000/  |k 1/60000/999810/  |p 5 
998 |g 1034853139  |a Welzel, Grit  |m 1034853139:Welzel, Grit  |d 60000  |d 63000  |e 60000PW1034853139  |e 63000PW1034853139  |k 0/60000/  |k 1/60000/63000/  |p 4 
998 |g 1033514756  |a Hartmann, Linda  |m 1033514756:Hartmann, Linda  |d 60000  |d 63000  |e 60000PH1033514756  |e 63000PH1033514756  |k 0/60000/  |k 1/60000/63000/  |p 3 
998 |g 1075006708  |a Kirschner, Stefanie  |m 1075006708:Kirschner, Stefanie  |d 60000  |d 63000  |e 60000PK1075006708  |e 63000PK1075006708  |k 0/60000/  |k 1/60000/63000/  |p 2 
998 |g 1139471937  |a Kübler, Jens  |m 1139471937:Kübler, Jens  |d 60000  |d 63000  |e 60000PK1139471937  |e 63000PK1139471937  |k 0/60000/  |k 1/60000/63000/  |p 1  |x j 
999 |a KXP-PPN1668783266  |e 3491984076 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 08.07.2019","Im Titel ist \"52-96\" tiefgestellt"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1668783266","language":["eng"],"person":[{"roleDisplay":"VerfasserIn","display":"Kübler, Jens","role":"aut","family":"Kübler","given":"Jens"},{"display":"Kirschner, Stefanie","roleDisplay":"VerfasserIn","role":"aut","family":"Kirschner","given":"Stefanie"},{"given":"Linda","family":"Hartmann","role":"aut","roleDisplay":"VerfasserIn","display":"Hartmann, Linda"},{"family":"Welzel","given":"Grit","roleDisplay":"VerfasserIn","display":"Welzel, Grit","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Engelhardt, Maren","role":"aut","family":"Engelhardt","given":"Maren"},{"given":"Carsten","family":"Herskind","role":"aut","display":"Herskind, Carsten","roleDisplay":"VerfasserIn"},{"given":"Marlon Romano","family":"Veldwijk","role":"aut","display":"Veldwijk, Marlon Romano","roleDisplay":"VerfasserIn"},{"given":"Christian","family":"Schultz","role":"aut","roleDisplay":"VerfasserIn","display":"Schultz, Christian"},{"family":"Felix","given":"Manuela","roleDisplay":"VerfasserIn","display":"Felix, Manuela","role":"aut"},{"given":"Gerhard","family":"Glatting","role":"aut","display":"Glatting, Gerhard","roleDisplay":"VerfasserIn"},{"family":"Maier","given":"Patrick","display":"Maier, Patrick","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Wenz, Frederik","roleDisplay":"VerfasserIn","role":"aut","family":"Wenz","given":"Frederik"},{"given":"Frank Anton","family":"Giordano","role":"aut","display":"Giordano, Frank Anton","roleDisplay":"VerfasserIn"}],"title":[{"title":"The HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivo","title_sort":"HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivo"}],"physDesc":[{"extent":"13 S."}],"relHost":[{"title":[{"title_sort":"OncoTarget","subtitle":"open access impact journal","title":"OncoTarget"}],"note":["Gesehen am 16.08.2018"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivoOncoTarget","language":["eng"],"recId":"63035975X","pubHistory":["1.2010,Mai -"],"part":{"text":"7(2016), 29, Seite 45500-45512","volume":"7","extent":"13","year":"2016","pages":"45500-45512","issue":"29"},"origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedKey":"2010","publisher":"Impact Journals LLC","dateIssuedDisp":"2010-"}],"id":{"issn":["1949-2553"],"eki":["63035975X"],"zdb":["2560162-3"]},"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Jens Kübler, Stefanie Kirschner, Linda Hartmann, Grit Welzel, Maren Engelhardt, Carsten Herskind, Marlon R. Veldwijk, Christian Schultz, Manuela Felix, Gerhard Glatting, Patrick Maier, Frederik Wenz, Marc A. Brockmann, Frank A. Giordano"]},"origin":[{"dateIssuedDisp":"June 2, 2016","dateIssuedKey":"2016"}],"id":{"eki":["1668783266"],"doi":["10.18632/oncotarget.9787"]}} 
SRT |a KUEBLERJENHIVDERIVED2201